Financials in USD. Standardized financial statements.
A compact view of how Molecule Holdings Inc. turns revenue into operating income and net income.
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|
| Revenue? | $1.97M | $455,257 | $0 | $0 |
| Revenue Growth? | +332.4% | 0.0% | 0.0% | 0.0% |
| Cost of Revenue? | $3.04M | $955,000 | $47,976 | $27,986 |
| Gross Profit? | -$1.07M | -$499,743 | -$47,976 | -$27,986 |
| Gross Margin? | -54.6% | -109.8% | 0.0% | 0.0% |
| Operating Expenses? | $2.84M | $2.89M | $1.83M | $1.10M |
| Operating Income? | -$3.91M | -$3.19M | -$1.88M | -$1.08M |
| EBITDA? | -$3.26M | -$2.87M | -$3.23M | -$1.05M |
| Income Before Tax | -$4.54M | -$4.23M | -$3.33M | -$1.09M |
| Income Tax Expense | $0 | $0 | $0 | $15,514 |
| Net Income? | -$4.54M | -$4.23M | -$3.33M | -$1.09M |
| EPS? | $-0.05 | $-0.05 | $-0.03 | $-0.24 |
| Diluted EPS? | $-0.05 | $-0.05 | $-0.03 | $-0.24 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality